ARTV vs POOL · rev $251.0K vs P/E 18, rev $5.31B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported ARTV revenue for 2024-12-31 was $251.0K. Net income was -$65.4M. Revenue was down 99.3% from 2023-12-31 to 2024-12-31. ARTV currently screens at market cap $37.3M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
ARTV currently screens at market cap $37.3M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the ARTV and POOL stock pages for the full models.
Not investment advice.